| Laboratory services: | |
| Drugs-of-abuse testing services | 11.71M |
| Clinical & other laboratory services | 9.58M |
| Clinical trial services | 2.15M |
| Product sales | 6.54M |
| Total revenues | 29.98M |
| COST OF REVENUES: | |
| Cost of services | 14.84M |
| Cost of sales | 2.5M |
| Total cost of revenues | 17.35M |
| GROSS PROFIT | 12.63M |
| OPERATING EXPENSES: | |
| Selling, general and administrative | 9.99M |
| Research and development | 755K |
| Total operating expenses | 10.75M |
| INCOME FROM OPERATIONS | 1.88M |
| OTHER INCOME (EXPENSE): | |
| Interest expense | 0 |
| Other income | 70K |
| Total other income (expense) | 70K |
| INCOME BEFORE INCOME TAX EXPENSE | 1.95M |
| INCOME TAX EXPENSE | -713K |
| NET INCOME | |
| BASIC EARNINGS PER COMMON SHARE (in dollars per share) | 0.14 |
| DILUTED EARNINGS PER COMMON SHARE (in dollars per share) | 0.14 |
| WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: | |
| Basic (in shares) | 8.9M |
| Diluted (in shares) | 9.13M |